Search results
How the love story between von der Leyen and Pfizer turned sour
Euronews via Yahoo News· 4 days agoFrom making her Europe’s vaccine saviour to becoming a skeleton in her closet: All the ebbs and...
Moderna wins case in patent dispute with Pfizer, BioNTech over COVID shot
WSAU Wausau· 4 days ago(Reuters) -Moderna has won a case at the European Patent Office in its dispute with Pfizer and...
Posts Claim Falsely That AstraZeneca Is Withdrawing Its COVID Vaccine Because of Blood Clots |...
The State· 5 days agoSince last week, hundreds of social media posts and news stories have claimed that AstraZeneca is removing its COVID vaccine from the market after admitting ...
How GSK CEO Emma Walmsley kept her job and turned a belligerent activist investor into an ally
Fortune· 12 hours agoA vaccine breakthrough helped Walmsley keep her job after the hedge fund known for taking stakes in underperforming companies argued in 2021 that Britain’s oldest drugmaker ...
VDHP fines Salem CVS Pharmacy $75k for improper COVID-19 vaccine doses, drug theft, and expired...
WDBJ 7 Roanoke· 4 days agoThe DHP says a contract nurse, who was improperly trained in diluting and administering vaccines,...
'New era of growth': AstraZeneca sets out bold plans for $80bn revenues by 2030
Evening Standard via Yahoo Finance· 12 hours agoCEO Pascal Soriot said: “Today AstraZeneca announces...profits of about $30 billion. The 20 new...
AstraZeneca targets $80 billion in total revenue by 2030 in 'post-Covid era'
CNBC· 13 hours agoThe Astrazeneca logo is pictured at the World Artificial Intelligence Conference 2021 in Shanghai,...
3 Healthcare Stocks to Buy Now: May 2024
InvestorPlace· 3 hours agoIt’s a great time to be looking at healthcare stocks to buy now. According to research from BlackRock, U.S. healthcare stocks have outperformed the...
Why Novavax (NVAX) Stock Price Appreciated 14% on Monday
Zacks via Yahoo Finance· 9 hours agoNovavax (NVAX) surges after one of its top shareholders drops a proxy campaign against the company....
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
Motley Fool via Yahoo Finance· 2 days agoNovavax is still developing a COVID-19/flu combination vaccine. It plans to start a phase 3 trial in...